Atlas Trials

Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer

Clinical trial NCT05162118 · UNKNOWN

Trial details

NCT number
NCT05162118
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Pancreatic Cancer
Start date
2022-03-08
Primary completion
2025-03-22
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.